ライフサイエンスコーパス: hydroxyquinoline

1 timicrobial tolerance to chloroxylenol and 8-hydroxyquinoline.

2 on-transfer behavior than that of its parent hydroxyquinoline.

3 ynthetic complex formed between Cu(2+) and 8-hydroxyquinoline.

4 lex proton-transfer behavior than its parent hydroxyquinoline.

5 ransfer between the gold nanoparticles and 8-hydroxyquinoline.

6 of corrosion of pure aluminum by CeCl3 and 8-hydroxyquinoline.

7 vailable quinolinols, as well as synthesized hydroxyquinolines.

8 works on both 2- and 4-hydroxypyridines and -hydroxyquinolines.

9 Isomeric 5-, 6-, 7-hydroxyquinolines (11-13) and 5-hydroxyisoquinoline (14)

10 d 11.1-14.8 MBq (300-400 micro Ci) (111)In-8-hydroxyquinoline ((111)In-oxine) or (111)In-mercaptopyri

11 ethers 17-19 by reductive amination using 8-hydroxyquinoline-2-carboxaldehyde.

12 N-Formylkynurenine (NFK) at pH 7.0 and 4-hydroxyquinoline (4-OH Q) and kynurenic acid (Kyn-A) at

13 Compounds 11, 13, 14, and 8-hydroxyquinoline (5) underwent selective ionic hydrogena

14 ing aluminum ions with the chelating agent 8-hydroxyquinoline-5-sulfonic acid (HQS) to form Al(HQS)3,

15 he Zn2+ chelators 1,10-O-phenanthroline or 8-hydroxyquinoline-5-sulfonic acid results in dissociation

16 The electrochemiluminescence (ECL) of tris(8-hydroxyquinoline-5-sulfonic acid)aluminum(III) in aqueou

17 zinc when treated with the metal chelator 8-hydroxyquinoline-5-sulfonic acid.

18 s utilized in the arrays comprise the same 8-hydroxyquinoline (8-HQ) receptor and various conjugated

19 The 8-hydroxyquinolines (8-HQ) clioquinol (CQ) and PBT2 were d

20 One group of hit compounds was 8-hydroxyquinolines (8-OHQ), a class of clinically relevan

21 Of approximately 30 hits, several were 8-hydroxyquinolines (8-OHQs).

22 helation-enhanced fluorescence property of 8-hydroxyquinoline (8HQ) following Ca(2+) complexation wit

23 arbomethoxy-2,2'-bipyridine 8 or 5-carboxy-8-hydroxyquinoline 9, two 2-oxoglutarate competitive templ

24 The sensor functionalized with 8-hydroxyquinoline allowed sensing through inducing Donnan

25 nterrogate interfaces formed between tris-(8-hydroxyquinoline) aluminum (Alq(3)) and vapor-deposited

26 l organic electroluminescent molecule tris(8-hydroxyquinoline) aluminum (Alq(3)).

27 of a thin-film organic semiconductor tris-(8-hydroxyquinoline) aluminum (Alq3) doped with DCM laser d

28 Working examples of tris(8-hydroxyquinoline)aluminum(III)-based OLEDs have been fab

29 e from an Alq(3)/TPD heterojunction (tris-(8-hydroxyquinoline)aluminum/N,N'-bis(3-methylphenyl)-N,N'-

30 The difference between the lowest energy hydroxyquinoline and quinolone forms is 27 and 38 kJ mol

31 eactions to generate in situ O,4-didehydro-2-hydroxyquinolines and O,4-didehydro-2-hydroxypyridines,

32 ry and abortive ternary complex containing 8-hydroxyquinoline, and contrast with previously reported

33 cules-ciclopirox olamine (CPX), piroctone, 8-hydroxyquinoline, and deferasirox-were also shown to eff

34 and we extended this effect to piroctone, 8-hydroxyquinoline, and deferasirox.

35 4-(2-hydroxyethyl) piperazin-1-yl (methyl)-8-hydroxyquinoline], and its derivative M30 [5-(N-methyl-N

36 nickel, lead and zinc at trace level using 8-hydroxyquinoline as a chelating agent and lanthanum(III)

37 ion of copper from biological samples with 8-hydroxyquinoline as a colorimetric indicator affords a m

38 izes tetraethylammonium carbonate as base, 8-hydroxyquinoline as ligand, and H2O as cosolvent.

39 is the first study providing evidence for 8-hydroxyquinolines as novel inhibitors of the IN-LEDGF/p7

40 sh this, fullerene was functionalized with 8-hydroxyquinoline at different ligand positions and their

41 equilibrium of the immobilized ligand, p-((8-hydroxyquinoline)azo)benzenethiol (SHQ).

42 scribe the synthesis of novel, red-shifted 8-hydroxyquinoline-based fluorophores and their incorporat

43 8-Bromo-7-hydroxyquinoline (BHQ) is efficiently photolyzed by clas

44 l synthesis is used to develop multiligand 8-hydroxyquinoline binding sites in porous silica structur

45 air of Q-PNA strands that each contain one 8-hydroxyquinoline, but below the melting temperature, the

46 c octadepsipeptides possessing two pendant 3-hydroxyquinoline chromophores, are described in which th

47 ry to previous reports, clioquinol and other hydroxyquinoline compounds do not act as direct proteaso

48 ifications at the C5 and C7 carbons of the 8-hydroxyquinoline core improved potency, but reduction of

49 hanum(III) as a carrier element, amount of 8-hydroxyquinoline, duration of co-precipitation was exami

50 Here, we report the discovery of a hydroxyquinoline family of small molecules that can acti

51 QE and 7Me-OQE show clear preference for the hydroxyquinoline form.

52 interface , we developed a set of modified 8-hydroxyquinoline fragments demonstrating micromolar IC50

53 such as Cu2+, Co2+, Ni2+, and Zn2+ bind to 8-hydroxyquinoline groups covalently attached to the PCCAC

54 2-Heptyl-4-hydroxyquinoline (HHQ) and Pseudomonas quinolone signal

55 s using the cocrystal structure of 5-nitro-8-hydroxyquinoline in the cathepsin B active site.

56 ve M30 [5-(N-methyl-N-propargyaminomethyl)-8-hydroxyquinoline] in vivo to test their neuroprotective

57 stent indications that cerium chloride and 8-hydroxyquinoline inhibit corrosion effectively.

58 onitored with the fiber, it was shown that 8-hydroxyquinoline is a more effective inhibitor than ceri

59 tended conjugated chromophores attached to 8-hydroxyquinoline is reported.

60 -yielding iodination of hydroxypyridines and hydroxyquinolines is described.

61 N-Oxidation of hydroxyquinolines leads to a dramatic increase in their

62 Strategic substitution of 8-hydroxyquinoline ligands and control of the structural s

63 ruthenium coordination complexes containing hydroxyquinoline ligands were synthesized that exhibited

64 The present study uses iron (Fe/hydroxyquinoline)-mediated injury of cultured human prox

65 olid-phase extraction of the analyte on an 8-hydroxyquinoline microcolumn.

66 ndependent tobramycin uptake, and 2-heptyl-4-hydroxyquinoline N-oxide (HQNO) induces multidrug tolera

67 lerae by the specific inhibitor 2-n-heptyl-4-hydroxyquinoline N-oxide (HQNO) resulted in elevated tox

68 and menD) or chemically, using 2-n-heptyl-4-hydroxyquinoline N-oxide (HQNO), inhibited both growth a

69 are sensitive to the inhibitor 2-n-heptyl-4-hydroxyquinoline N-oxide (HQNO).

70 one, gramicidin, Triton X-100, or 2-heptyl-4-hydroxyquinoline N-oxide (HQNO).

71 The addition of 2-(n-heptyl)-4-hydroxyquinoline N-oxide to whole cells or purified memb

72 ubiquinone or its analog HQNO (2-n-heptyl-4-hydroxyquinoline N-oxide) from Na(+)-NQR, which indicate

73 f Na(+)-NQR inhibitor (DBMIB or 2-n-heptyl-4-hydroxyquinoline N-oxide) indicate that two quinone anal

74 tridecyl-stigmatellin) and 3.25-A (2-nonyl-4-hydroxyquinoline N-oxide) resolution.

75 quinone analogues menadione and 2-n-heptyl-4-hydroxyquinoline N-oxide, identifying a hydrophobic plat

76 tween ubiquinone-1 and DBMIB or 2-n-heptyl-4-hydroxyquinoline N-oxide, respectively.

77 sic and more acidic than the parent and adds hydroxyquinoline N-oxides to the class of high-acidity e

78 We demonstrate here that 2-n-heptyl-4-hydroxyquinoline-N-oxide (HQNO), a Pseudomonas aeruginos

79 branes were highly sensitive to 2-n-heptyl-4-hydroxyquinoline-N-oxide (IC(5)(0) = approximately 1 mum

80 wn quinol-binding site inhibitors 2-heptyl-4-hydroxyquinoline-N-oxide and 2-[1-(p-chlorophenyl)ethyl]

81 steady-state emission characterization of 6-hydroxyquinoline-N-oxide and 2-methyl-6-hydroxyquinoline

82 n combination with antimycin or 2-n-heptyl-4-hydroxyquinoline-N-oxide in combination with myxothiazol

83 of 6-hydroxyquinoline-N-oxide and 2-methyl-6-hydroxyquinoline-N-oxide reveals a rich but less complex

84 er antimycin or myxothiazol (or 2-n-heptyl-4-hydroxyquinoline-N-oxide, (E)-methyl-3-methoxy-2-(4'-tra

85 the effect of the Q(i) site inhibitor 2-N-4-hydroxyquinoline-N-oxide.

86 ecific inhibitors myxothiazol and 2-heptyl-4-hydroxyquinoline-N-oxide.

87 We have introduced 8-hydroxyquinoline Q in 10-mer PNA strands with various se

88 Herein, we investigated 8-hydroxyquinoline (quinolin-8-ol) as a potential inhibito

89 ene film containing gold nanoparticles and 8-hydroxyquinoline sandwiched between two metal electrodes

90 atrithia-16-crown-5 ligands containing two 8-hydroxyquinoline sidearms are reported.

91 Thus, the possibility of 4-oxoquinoline/4-hydroxyquinoline tautomerism may impact in pharmacologic

92 ations form bisliganded complexes with two 8-hydroxyquinolines that cross-link the hydrogel and cause

93 1% m/v 8-Hydroxyquinoline was used as the modifier to enhance the

94 A specific PON1 inhibitor, 2-hydroxyquinoline, was used to confirm that the observed

95 rable binding of the "privileged" fragment 8-hydroxyquinoline with HIV-1 integrase (IN) at the IN-len

96 acuum-deposited thin films of zinc(II) bis(8-hydroxyquinoline) (Znq(2)).